Back to LYEL

CITADEL ADVISORS LLC → LYEL

CITADEL ADVISORS LLC LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
9
Latest value
$386K
Q3 2026
Peak value
$1M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$239K
Q2 2026$263K
Q2 2026$251K
Q2 2026$239K
Q2 2026$263K
Q2 2026$251K
Q3 2026$244K
Q3 2026$1M
Q3 2026$386K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$386K39.4K——
Q3 2026$1M106.7K——
Q3 2026$244K24.9K——
Q2 2026$251K17.9K——
Q2 2026$263K18.7K——
Q2 2026$239K17.0K——
Q2 2026$251K17.9K——
Q2 2026$263K18.7K——
Q2 2026$239K17.0K——

Other funds holding LYEL

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B